TB-500 Fragment 17-23 10 mg – Actin-Modulating Research Peptide Fragment FOR LABORATORY RESEARCH USE ONLY – NOT FOR HUMAN OR VETERINARY CONSUMPTION. Scientific Background TB-500 Fragment 17-23 is a short peptide fragment derived from thymosin beta-4 (TB-4) and is under investigation in laboratory settings related to cytoskeletal dynamics. In research models, TB-4–related sequences are commonly explored for potential interactions with actin-regulation pathways and for use in studying cell migration, tissue remodeling signaling, and related in-vitro assay systems. Specification Peptide Name: TB-500 Fragment 17-23 (TB-4 Fragment 17-23) Content: 10 mg lyophilized powder (requires reconstitution) Purity: ≥ 99% (HPLC / MS certificate available) Manufacturing: ISO 9001:2015 & cGMP-audited facility Intended Use: In-vitro laboratory research only Storage & Handling Prior to reconstitution: store ≤ 8 °C in a dry environment After reconstitution: refrigerate 2 – 8 °C and use within 30 days For extended preservation: aliquot and freeze at −20 °C Avoid repeated freeze–thaw cycles Compliance Notice Supplied exclusively to qualified professionals for controlled laboratory applications. No dosage or administration guidance is provided. Buyer assumes responsibility for safe handling and regulatory adherence.